Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Spatial Monitoring of Pathogen Spread in Ambrosia Beetle Col
2026-06-11
Masoudi et al. introduce a detailed laboratory protocol for spatially sampling and tracking infectious disease dynamics in social ambrosia beetle colonies. By integrating controlled rearing, fungal infection assays, and spatially resolved analyses, the study provides a reproducible framework to investigate microbial transmission and symbiont dynamics in insect societies.
-
GSK621: Precision AMPK Agonist Workflows for AML & Metabolic
2026-06-11
GSK621, a potent AMPK agonist from APExBIO, empowers acute myeloid leukemia and immunometabolic research with high reproducibility and specificity. This guide unpacks advanced use-cases, stepwise protocols, and troubleshooting strategies for maximizing GSK621’s impact across metabolic and cell fate assays.
-
WM-8014: Precision KAT6A Inhibitor for Cancer Biology Resear
2026-06-10
WM-8014 empowers researchers to dissect oncogene-induced senescence and cell cycle arrest with high selectivity and minimal cytotoxicity. Its performance in both in vitro and in vivo models, and compatibility with advanced screening workflows, makes it a cornerstone for translational epigenetic drug target studies.
-
Heparin Sodium: Beyond Thrombosis—Frontiers in Anticoagulant
2026-06-10
Explore the advanced roles of Heparin sodium as a glycosaminoglycan anticoagulant in cutting-edge research, including mechanistic insights, innovative delivery strategies, and assay optimization. This cornerstone article reveals applications and evidence not covered in standard thrombosis protocols.
-
Intestinal TM6SF2 Modulates MASH via Gut–Liver Axis Mechanis
2026-06-09
The referenced Nature Metabolism study demonstrates that intestinal TM6SF2 exerts a protective effect against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and regulating microbiota composition. These findings highlight lysophosphatidic acid (LPA) signaling and host–microbe interactions as central mechanisms, offering new therapeutic targets for MASH intervention.
-
Palmitic acid (Hexadecanoic Acid): Technical Guidance & Prot
2026-06-09
Palmitic acid (hexadecanoic acid, SKU N2456) is a high-purity, well-characterized saturated long-chain fatty acid for in vitro research. It is best suited for studies involving lipid metabolism, protein palmitoylation, and metabolic disorder models, but is not appropriate for protocols requiring aqueous solubility or long-term solution stability.
-
Applied Uses of Q-VD(OMe)-OPh in Apoptosis and Neuroprotecti
2026-06-08
Q-VD(OMe)-OPh stands out as a non-toxic, broad-spectrum pan-caspase inhibitor that delivers superior specificity and reproducibility in apoptosis research. Discover how this APExBIO reagent streamlines experimental workflows and enables translational advances in cancer, neuroprotection, and cell-based assays.
-
Oral Gepotidacin Non-Inferior to Standard Therapy for Gonorr
2026-06-08
The EAGLE-1 phase 3 trial demonstrates that gepotidacin, a novel oral bacterial DNA replication inhibitor, is non-inferior to standard ceftriaxone plus azithromycin therapy for uncomplicated urogenital gonorrhoea. This provides robust clinical evidence for a new oral treatment option amid rising antibiotic resistance.
-
IEM 1460: Optimizing AMPA Receptor Blockade in Neuroprotecti
2026-06-07
Harness the precision of IEM 1460, a selective AMPA receptor blocker, to advance excitotoxicity and neuroprotection research. This guide translates leading-edge findings into actionable workflows, robust troubleshooting, and assay enhancements for reliable, reproducible results.
-
Cl-Amidine trifluoroacetate salt: Precision PAD4 Inhibition
2026-06-06
Cl-Amidine (trifluoroacetate salt) empowers researchers to dissect PAD4-mediated pathways with unmatched selectivity, enabling robust experimental workflows in cancer, autoimmune, and sepsis models. This article translates cutting-edge mechanistic insights and reference breakthroughs into actionable protocols and troubleshooting strategies for translational research.
-
Protease Inhibitor Cocktail EDTA-Free: Innovations for Next-
2026-06-05
Explore how the Protease Inhibitor Cocktail EDTA-Free advances protein extraction beyond conventional protocols. This article uniquely connects recent mitocytosis research to practical optimization for phosphorylation-sensitive and high-complexity assays.
-
Cytokine and Glucocorticoid Regulation of BIRC2/3 in Lung Ep
2026-06-05
The referenced study delineates how inflammatory cytokines and glucocorticoids distinctly regulate BIRC2 and BIRC3 gene expression in human pulmonary epithelial cells. These findings advance our mechanistic understanding of apoptosis regulation and inflammatory signaling in the respiratory epithelium, with implications for research on epithelial homeostasis and disease.
-
Silybin A: Precision Hepatoprotection and Metabolic Modulati
2026-06-04
Exploring the mechanistic and translational edge of Silybin A, a bioactive core of Silymarin, this article merges molecular insight with actionable protocol guidance. Drawing on recent CRISPRi advances in adipocyte targeting, we highlight strategic opportunities for researchers tackling liver disease, obesity, and metabolic syndromes, and position Silybin A (APExBIO) as an advanced lever for next-generation experimental design.
-
Streptavidin-Cy3: Optimizing Biotin Detection in Cancer Assa
2026-06-04
Streptavidin-Cy3 from APExBIO elevates biotin detection with robust, bright Cy3 fluorescence and unmatched binding specificity. This guide translates recent breakthroughs in nasopharyngeal carcinoma research into actionable workflow strategies, troubleshooting tactics, and advanced applications for immunohistochemistry and flow cytometry.
-
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole: Deep Mechanis
2026-06-03
Explore how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) uniquely advances transcriptional inhibition research by bridging CDK signaling, RNA polymerase II regulation, and cutting-edge epitranscriptomic discoveries. This article unveils new mechanistic depth and actionable guidance for scientists seeking to optimize assay design and interpretation.